Rheonmedical

1 known investors

Rheon Medical develops the eyeWatch, an adjustable glaucoma shunt implant that lets physicians titrate aqueous flow to lower intraocular pressure while preventing early hypotony. The device is used in glaucoma surgery to reduce patients' reliance on anti-glaucoma medications.